Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Schattenberg
L Stump

Showing results (281-290 of 392) with videos related to

Pageof 40
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|July 16, 2025
Metabolic Dysfunction-Associated Steatohepatitis Diagnosis and Management in Germany: Insights From an Expert Consensus PanelYestle Kim, Peter Rydqvist, Thomas Ramezani, et al.
European Journal of Heart Failure|September 26, 2025
Incidence of major cardiovascular events in patients with metabolic dysfunction-associated steatotic liver disease in the general populationYvonne Huber, Lea Hofmann, Jürgen H Prochaska, et al.
Plos One|June 22, 2026
Hearing loss and executive functions - results from a population-based cohort studyJulia Döge, Daniëlle Otten, Berit Hackenberg, et al.
Nature Communications|April 29, 2017
Elevated levels of Bcl-3 inhibits Treg development and function resulting in spontaneous colitisSonja Reißig, Yilang Tang, Alexei Nikolaev, et al.
Gastroenterology|October 14, 2018
Alternative Splice Forms of CYLD Mediate Ubiquitination of SMAD7 to Prevent TGFB Signaling and Promote ColitisYilang Tang, Sonja Reissig, Elke Glasmacher, et al.
JHEP Reports : Innovation in Hepatology|August 11, 2020
Cost of non-alcoholic steatohepatitis in Europe and the USA: The GAIN studyJamie O'Hara, Alan Finnegan, Harpal Dhillon, et al.
Zeitschrift Fur Gastroenterologie|November 15, 2022
Bevacizumab in combination with octreotide rescues a patient with liver cirrhosis, GAVE syndrome and refractory hemorrhage - a case reportSimon Johannes Gairing, Eva Maria Schleicher, Lukas Müller, et al.
Biomedicines|December 24, 2021
Systematic Review with Meta-Analysis: Diagnostic Accuracy of Pro-C3 for Hepatic Fibrosis in Patients with Non-Alcoholic Fatty Liver DiseaseAnne Linde Mak, Jenny Lee, Anne-Marieke van Dijk, et al.
The American Journal of Gastroenterology|November 30, 2020
A Sequential Algorithm Combining ADAPT and Liver Stiffness Can Stage Metabolic-Associated Fatty Liver Disease in Hospital-Based and Primary Care PatientsMohammed Eslam, Grace Lai-Hung Wong, Ahmed M Hashem, et al.
The American Journal of Gastroenterology|October 12, 2016
Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD FibrosisStuart McPherson, Tim Hardy, Jean-Francois Dufour, et al.
Pageof 40

Showing results (281-290 of 392) with videos related to

Sort By:
Pageof 40
Liver International : Official Journal of the International Association for the Study of the Liver|July 16, 2025
Metabolic Dysfunction-Associated Steatohepatitis Diagnosis and Management in Germany: Insights From an Expert Consensus PanelYestle Kim, Peter Rydqvist, Thomas Ramezani, et al.
European Journal of Heart Failure|September 26, 2025
Incidence of major cardiovascular events in patients with metabolic dysfunction-associated steatotic liver disease in the general populationYvonne Huber, Lea Hofmann, Jürgen H Prochaska, et al.
Plos One|June 22, 2026
Hearing loss and executive functions - results from a population-based cohort studyJulia Döge, Daniëlle Otten, Berit Hackenberg, et al.
Nature Communications|April 29, 2017
Elevated levels of Bcl-3 inhibits Treg development and function resulting in spontaneous colitisSonja Reißig, Yilang Tang, Alexei Nikolaev, et al.
Gastroenterology|October 14, 2018
Alternative Splice Forms of CYLD Mediate Ubiquitination of SMAD7 to Prevent TGFB Signaling and Promote ColitisYilang Tang, Sonja Reissig, Elke Glasmacher, et al.
JHEP Reports : Innovation in Hepatology|August 11, 2020
Cost of non-alcoholic steatohepatitis in Europe and the USA: The GAIN studyJamie O'Hara, Alan Finnegan, Harpal Dhillon, et al.
Zeitschrift Fur Gastroenterologie|November 15, 2022
Bevacizumab in combination with octreotide rescues a patient with liver cirrhosis, GAVE syndrome and refractory hemorrhage - a case reportSimon Johannes Gairing, Eva Maria Schleicher, Lukas Müller, et al.
Biomedicines|December 24, 2021
Systematic Review with Meta-Analysis: Diagnostic Accuracy of Pro-C3 for Hepatic Fibrosis in Patients with Non-Alcoholic Fatty Liver DiseaseAnne Linde Mak, Jenny Lee, Anne-Marieke van Dijk, et al.
The American Journal of Gastroenterology|November 30, 2020
A Sequential Algorithm Combining ADAPT and Liver Stiffness Can Stage Metabolic-Associated Fatty Liver Disease in Hospital-Based and Primary Care PatientsMohammed Eslam, Grace Lai-Hung Wong, Ahmed M Hashem, et al.
The American Journal of Gastroenterology|October 12, 2016
Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD FibrosisStuart McPherson, Tim Hardy, Jean-Francois Dufour, et al.
Pageof 40